ResMed Inc holds recent Real Value of $83.30494999999999 per share. The prevailing price of the company is $88.58. At this time the company appears to be over valued. Macroaxis determines value of ResMed Inc from analyzing the company fundamentals such as Shares Outstanding of 141.9M, Operating Margin of
22.36% and Return On Equity of 18.43% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we support investing in undervalued entities and to dispose of overvalued entities since at some point stocks prices and their ongoing real values will merge together.
Valuation Drivers Correlation
|Time Horizon||30 Days Login to change|
ResMed Inc is rated third in price to sales category among related companies. It is rated fifth in beta category among related companies totaling about 0.13 of Beta per Price to Sales. The ratio of Price to Sales to Beta for ResMed Inc is roughly 7.45
ResMed is not too risky asset. Calculation of real value of ResMed Inc is based on 1 month time horizon. Increasing ResMed Inc time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.